Clinical management of vestibular schwannoma - what's the evidence?

Clinical management of vestibular schwannomas (VS) encompasses three main strategies: observation ("wait-and-scan"), stereotactic radiosurgery, and microsurgery. Despite extensive literature, a consensus on the optimal modality is lacking due to the scarcity of high-level evidence.

This evidence review may reinforce or refine multidisciplinary decision-making for vestibular schwannoma management, but no single management strategy is universally superior; clinicians should continue individualising care based on tumor size, growth rate, patient age, and hearing status.

Vestibular schwannoma management sits at the intersection of audiology, neurotology, and neurosurgery, and an up-to-date evidence synthesis helps audiologists contribute meaningfully to shared decision-making and counselling.

1. 01Three management strategies reviewed: observation ('wait and scan'), stereotactic radiosurgery, and microsurgical resection.
2. 02Published in Acta Neurochirurgica (2026), a peer-reviewed neurosurgical journal.
3. 03Evidence quality for each strategy likely varies; comparative effectiveness data remain limited by heterogeneous study designs.
4. 04Audiologists play a role in pre- and post-treatment hearing assessment regardless of management pathway.
5. 05Findings may inform multidisciplinary team guidelines and patient counselling conversations.

PMID

42435085

DOI

10.1007/s00701-026-06949-6.

Journal

Acta Neurochirurgica

Publication type

review

Evidence level

5

Population

Patients with vestibular schwannoma across management strategy cohorts

Intervention

Observation, stereotactic radiosurgery, and microsurgical resection for vestibular schwannoma

Comparator

Comparative review of all three strategies against each other